Adrenoceptor blockade in hypertension: a symposium of Glaxo, Sweden, Skövde, 8 - 9 October, 1981
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Stockholm
Almqvist & Wiksell
1982
|
| Schriftenreihe: | Acta medica Scandinavica / Suppl.
665 |
| Schlagworte: | |
| Beschreibung: | 147 S. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV000343987 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 870612s1982 |||| 00||| eng d | ||
| 035 | |a (OCoLC)11443488 | ||
| 035 | |a (DE-599)BVBBV000343987 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-19 |a DE-355 |a DE-20 |a DE-29 | ||
| 050 | 0 | |a R81 | |
| 084 | |a YB 1505 |0 (DE-625)153103:12911 |2 rvk | ||
| 245 | 1 | 0 | |a Adrenoceptor blockade in hypertension |b a symposium of Glaxo, Sweden, Skövde, 8 - 9 October, 1981 |c ed. by Karl-Erik Andersson ... |
| 264 | 1 | |a Stockholm |b Almqvist & Wiksell |c 1982 | |
| 300 | |a 147 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Acta medica Scandinavica / Suppl. |v 665 | |
| 650 | 7 | |a Adrenoceptoren |2 gtt | |
| 650 | 7 | |a Alpha-bloquants - Congrès |2 ram | |
| 650 | 7 | |a Blokkade |2 gtt | |
| 650 | 7 | |a Bêta-bloquants - Congrès |2 ram | |
| 650 | 7 | |a Hypertensie |2 gtt | |
| 650 | 7 | |a Hypertension artérielle - Congrès |2 ram | |
| 650 | 4 | |a Adrenergic alpha-Antagonists |x pharmacology |v Congresses | |
| 650 | 4 | |a Adrenergic alpha-Antagonists |x therapeutic use |v Congresses | |
| 650 | 4 | |a Adrenergic beta blockers |v Congresses | |
| 650 | 4 | |a Adrenergic beta-Antagonists |x pharmacology |v Congresses | |
| 650 | 4 | |a Adrenergic beta-Antagonists |x therapeutic use |v Congresses | |
| 650 | 4 | |a Ethanolamines |x therapeutic use |v Congresses | |
| 650 | 4 | |a Hypertension |x Chemotherapy |v Congresses | |
| 650 | 4 | |a Hypertension |x drug therapy |v Congresses | |
| 650 | 4 | |a Hypotensive agents |v Congresses | |
| 650 | 4 | |a Labetalol |v Congresses | |
| 650 | 0 | 7 | |a Beta-Blocker |0 (DE-588)4006088-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hypertonie |0 (DE-588)4026372-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Alpha-Blocker |0 (DE-588)4142002-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1981 |z Skövde |2 gnd-content | |
| 689 | 0 | 0 | |a Beta-Blocker |0 (DE-588)4006088-3 |D s |
| 689 | 0 | 1 | |a Hypertonie |0 (DE-588)4026372-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Hypertonie |0 (DE-588)4026372-1 |D s |
| 689 | 1 | 1 | |a Alpha-Blocker |0 (DE-588)4142002-0 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Hypertonie |0 (DE-588)4026372-1 |D s |
| 689 | 2 | 1 | |a Beta-Blocker |0 (DE-588)4006088-3 |D s |
| 689 | 2 | |5 DE-604 | |
| 700 | 1 | |a Andersson, Karl-Erik |e Sonstige |4 oth | |
| 710 | 2 | |a Glaxo Läkemedel AB (Mölndal) |e Sonstige |0 (DE-588)1080347-6 |4 oth | |
| 810 | 2 | |a Suppl. |t Acta medica Scandinavica |v 665 |w (DE-604)BV000000651 |9 665 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-000213736 | ||
Datensatz im Suchindex
| _version_ | 1804114811130216448 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV000343987 |
| callnumber-first | R - Medicine |
| callnumber-label | R81 |
| callnumber-raw | R81 |
| callnumber-search | R81 |
| callnumber-sort | R 281 |
| callnumber-subject | R - General Medicine |
| classification_rvk | YB 1505 |
| ctrlnum | (OCoLC)11443488 (DE-599)BVBBV000343987 |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02533nam a2200649 cb4500</leader><controlfield tag="001">BV000343987</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">870612s1982 |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)11443488</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000343987</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-29</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">R81</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YB 1505</subfield><subfield code="0">(DE-625)153103:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Adrenoceptor blockade in hypertension</subfield><subfield code="b">a symposium of Glaxo, Sweden, Skövde, 8 - 9 October, 1981</subfield><subfield code="c">ed. by Karl-Erik Andersson ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Stockholm</subfield><subfield code="b">Almqvist & Wiksell</subfield><subfield code="c">1982</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">147 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Acta medica Scandinavica / Suppl.</subfield><subfield code="v">665</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Adrenoceptoren</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alpha-bloquants - Congrès</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Blokkade</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bêta-bloquants - Congrès</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hypertensie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hypertension artérielle - Congrès</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adrenergic alpha-Antagonists</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adrenergic alpha-Antagonists</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adrenergic beta blockers</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adrenergic beta-Antagonists</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adrenergic beta-Antagonists</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ethanolamines</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypertension</subfield><subfield code="x">Chemotherapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypertension</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypotensive agents</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Labetalol</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Beta-Blocker</subfield><subfield code="0">(DE-588)4006088-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hypertonie</subfield><subfield code="0">(DE-588)4026372-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Alpha-Blocker</subfield><subfield code="0">(DE-588)4142002-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1981</subfield><subfield code="z">Skövde</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Beta-Blocker</subfield><subfield code="0">(DE-588)4006088-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Hypertonie</subfield><subfield code="0">(DE-588)4026372-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Hypertonie</subfield><subfield code="0">(DE-588)4026372-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Alpha-Blocker</subfield><subfield code="0">(DE-588)4142002-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Hypertonie</subfield><subfield code="0">(DE-588)4026372-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Beta-Blocker</subfield><subfield code="0">(DE-588)4006088-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Andersson, Karl-Erik</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Glaxo Läkemedel AB (Mölndal)</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1080347-6</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Suppl.</subfield><subfield code="t">Acta medica Scandinavica</subfield><subfield code="v">665</subfield><subfield code="w">(DE-604)BV000000651</subfield><subfield code="9">665</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000213736</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1981 Skövde gnd-content |
| genre_facet | Konferenzschrift 1981 Skövde |
| id | DE-604.BV000343987 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T15:12:39Z |
| institution | BVB |
| institution_GND | (DE-588)1080347-6 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000213736 |
| oclc_num | 11443488 |
| open_access_boolean | |
| owner | DE-12 DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-20 DE-29 |
| owner_facet | DE-12 DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-20 DE-29 |
| physical | 147 S. |
| publishDate | 1982 |
| publishDateSearch | 1982 |
| publishDateSort | 1982 |
| publisher | Almqvist & Wiksell |
| record_format | marc |
| series2 | Acta medica Scandinavica / Suppl. |
| spelling | Adrenoceptor blockade in hypertension a symposium of Glaxo, Sweden, Skövde, 8 - 9 October, 1981 ed. by Karl-Erik Andersson ... Stockholm Almqvist & Wiksell 1982 147 S. txt rdacontent n rdamedia nc rdacarrier Acta medica Scandinavica / Suppl. 665 Adrenoceptoren gtt Alpha-bloquants - Congrès ram Blokkade gtt Bêta-bloquants - Congrès ram Hypertensie gtt Hypertension artérielle - Congrès ram Adrenergic alpha-Antagonists pharmacology Congresses Adrenergic alpha-Antagonists therapeutic use Congresses Adrenergic beta blockers Congresses Adrenergic beta-Antagonists pharmacology Congresses Adrenergic beta-Antagonists therapeutic use Congresses Ethanolamines therapeutic use Congresses Hypertension Chemotherapy Congresses Hypertension drug therapy Congresses Hypotensive agents Congresses Labetalol Congresses Beta-Blocker (DE-588)4006088-3 gnd rswk-swf Hypertonie (DE-588)4026372-1 gnd rswk-swf Alpha-Blocker (DE-588)4142002-0 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1981 Skövde gnd-content Beta-Blocker (DE-588)4006088-3 s Hypertonie (DE-588)4026372-1 s DE-604 Alpha-Blocker (DE-588)4142002-0 s Andersson, Karl-Erik Sonstige oth Glaxo Läkemedel AB (Mölndal) Sonstige (DE-588)1080347-6 oth Suppl. Acta medica Scandinavica 665 (DE-604)BV000000651 665 |
| spellingShingle | Adrenoceptor blockade in hypertension a symposium of Glaxo, Sweden, Skövde, 8 - 9 October, 1981 Adrenoceptoren gtt Alpha-bloquants - Congrès ram Blokkade gtt Bêta-bloquants - Congrès ram Hypertensie gtt Hypertension artérielle - Congrès ram Adrenergic alpha-Antagonists pharmacology Congresses Adrenergic alpha-Antagonists therapeutic use Congresses Adrenergic beta blockers Congresses Adrenergic beta-Antagonists pharmacology Congresses Adrenergic beta-Antagonists therapeutic use Congresses Ethanolamines therapeutic use Congresses Hypertension Chemotherapy Congresses Hypertension drug therapy Congresses Hypotensive agents Congresses Labetalol Congresses Beta-Blocker (DE-588)4006088-3 gnd Hypertonie (DE-588)4026372-1 gnd Alpha-Blocker (DE-588)4142002-0 gnd |
| subject_GND | (DE-588)4006088-3 (DE-588)4026372-1 (DE-588)4142002-0 (DE-588)1071861417 |
| title | Adrenoceptor blockade in hypertension a symposium of Glaxo, Sweden, Skövde, 8 - 9 October, 1981 |
| title_auth | Adrenoceptor blockade in hypertension a symposium of Glaxo, Sweden, Skövde, 8 - 9 October, 1981 |
| title_exact_search | Adrenoceptor blockade in hypertension a symposium of Glaxo, Sweden, Skövde, 8 - 9 October, 1981 |
| title_full | Adrenoceptor blockade in hypertension a symposium of Glaxo, Sweden, Skövde, 8 - 9 October, 1981 ed. by Karl-Erik Andersson ... |
| title_fullStr | Adrenoceptor blockade in hypertension a symposium of Glaxo, Sweden, Skövde, 8 - 9 October, 1981 ed. by Karl-Erik Andersson ... |
| title_full_unstemmed | Adrenoceptor blockade in hypertension a symposium of Glaxo, Sweden, Skövde, 8 - 9 October, 1981 ed. by Karl-Erik Andersson ... |
| title_short | Adrenoceptor blockade in hypertension |
| title_sort | adrenoceptor blockade in hypertension a symposium of glaxo sweden skovde 8 9 october 1981 |
| title_sub | a symposium of Glaxo, Sweden, Skövde, 8 - 9 October, 1981 |
| topic | Adrenoceptoren gtt Alpha-bloquants - Congrès ram Blokkade gtt Bêta-bloquants - Congrès ram Hypertensie gtt Hypertension artérielle - Congrès ram Adrenergic alpha-Antagonists pharmacology Congresses Adrenergic alpha-Antagonists therapeutic use Congresses Adrenergic beta blockers Congresses Adrenergic beta-Antagonists pharmacology Congresses Adrenergic beta-Antagonists therapeutic use Congresses Ethanolamines therapeutic use Congresses Hypertension Chemotherapy Congresses Hypertension drug therapy Congresses Hypotensive agents Congresses Labetalol Congresses Beta-Blocker (DE-588)4006088-3 gnd Hypertonie (DE-588)4026372-1 gnd Alpha-Blocker (DE-588)4142002-0 gnd |
| topic_facet | Adrenoceptoren Alpha-bloquants - Congrès Blokkade Bêta-bloquants - Congrès Hypertensie Hypertension artérielle - Congrès Adrenergic alpha-Antagonists pharmacology Congresses Adrenergic alpha-Antagonists therapeutic use Congresses Adrenergic beta blockers Congresses Adrenergic beta-Antagonists pharmacology Congresses Adrenergic beta-Antagonists therapeutic use Congresses Ethanolamines therapeutic use Congresses Hypertension Chemotherapy Congresses Hypertension drug therapy Congresses Hypotensive agents Congresses Labetalol Congresses Beta-Blocker Hypertonie Alpha-Blocker Konferenzschrift 1981 Skövde |
| volume_link | (DE-604)BV000000651 |
| work_keys_str_mv | AT anderssonkarlerik adrenoceptorblockadeinhypertensionasymposiumofglaxoswedenskovde89october1981 AT glaxolakemedelabmolndal adrenoceptorblockadeinhypertensionasymposiumofglaxoswedenskovde89october1981 |